NCT03063593 is a clinical trial in Arthritis, Rheumatoid, sponsored by Stryker Trauma and Extremities.

Who is sponsoring NCT03063593?

NCT03063593 is sponsored by Stryker Trauma and Extremities.

What condition does NCT03063593 study?

NCT03063593 studies Arthritis, Rheumatoid, Post-traumatic Osteoarthritis, Degenerative Arthritis.

Is NCT03063593 still recruiting?

NCT03063593 is currently active, enrolled. Last updated 20 January 2026.

Last reviewed 2026-01-20 · How we verify

NCT03063593

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UK Infinity, Post-Market Clinical Follow-up Study

Active, enrolled Last updated 20 January 2026

What this trial tests

trial in Arthritis, Rheumatoid in 500 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

29 April 2016

Primary endpoint
31 December 2029

31 December 2029

Quick facts

Lead sponsor	Stryker Trauma and Extremities
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	500
Start date	29 April 2016
Primary completion	31 December 2029
Estimated completion	31 December 2029
Sites	12 locations across United Kingdom

Conditions studied

Arthritis, Rheumatoid — all drugs for Arthritis, Rheumatoid →
Post-traumatic Osteoarthritis — all drugs for Post-traumatic Osteoarthritis →
Degenerative Arthritis — all drugs for Degenerative Arthritis →

Sponsor

Stryker Trauma and Extremities — full company profile →

Who can join

21 and older, any sex, with Arthritis, Rheumatoid or Post-traumatic Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System Number of Subjects 500 with 10 sites

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Early experience and patient-reported outcomes of 503 INFINITY total ankle arthroplasties.
Townshend DN, Bing AJF, Clough TM, Sharpe IT, et al · · 2021 · cited 20× · PMID 34192928 · DOI 10.1302/0301-620x.103b7.bjj-2020-2058.r2
Two to Five-Year Outcomes of Total Ankle Arthroplasty with the Infinity Fixed-Bearing Implant: A Concise Follow-up of a Previous Report.
Townshend D, Bing A, Blundell C, Clough T, et al · · 2023 · cited 6× · PMID 38063779 · DOI 10.2106/jbjs.22.01294

Verify or expand the search:

Other recruiting trials for Arthritis, Rheumatoid

Currently open trials in the same condition.

NCT07176390 — A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) · Phase 2 · recruiting
NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
NCT06528431 — Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study · Phase 4 · recruiting
NCT06492200 — Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis · NA · recruiting
NCT06246123 — A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants · recruiting

Other Stryker Trauma and Extremities trials

Trials by the same sponsor.

NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
NCT06080412 — Blueprint® Mixed Reality Pilot Study · completed
NCT06829667 — Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability · enrolling by invitation
NCT05773352 — Perform® Humeral System - Fracture Study (PFX) · active not recruiting
NCT06638138 — Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03063593 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stryker Trauma and Extremities
Last refreshed: 20 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03063593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing